Our Vision

Transforming cancer services to deliver better outcomes for patients in the East of England

Prostate Pathway Redesign

We will redesign the prostate pathway to rollout the 28-days to diagnosis standard, replacing the two-week wait / 62-day pathway to reflect new evidence on low-risk prostate cancer.  At 28 days, patients will be placed on risk-stratified pathways and commence subsequent treatment within 31 days of shared decision to treat. 

The cohort with low-risk prostate will have mpMRI scans to exclude prostate cancer. Any patients with a clinical suspicion of cancer will be referred on a 62-day pathway. This will remove the need for prostate biopsy.

Shaping excellence in cancer care - prevention and access to high quality cancer services across the East of England